Recombinant EPHA3 (Ifabotuzumab Biosimilar) antibody
This anti-EPHA3 (Ifabotuzumab Biosimilar) antibody is a Human Monoclonal antibody detecting EPHA3 (Ifabotuzumab Biosimilar) in ELISA, FACS, BLI, Func and SPR. Suitable for Human.
Catalog No. ABIN7675977
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant EPHA3 (Ifabotuzumab Biosimilar) antibody (ABIN7675977)
Target
EPHA3 (Ifabotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This EPHA3 (Ifabotuzumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-EphA3 Reference Antibody (ifabotuzumab)
-
Characteristics
- Anti-EphA3 Reference Antibody (ifabotuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG1
-
-
anti-EPHA3 (Ifabotuzumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- EPHA3 (Ifabotuzumab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- P29320
Target
-
You are here:
